Comparison of the ALKA and CRS scores to predict outcomes among patients with coronavirus disease 2019 infection in United Arab Emirates.

ABSTRACT:

Introduction

The coronavirus disease 2019 (COVID-19) pandemic resulted in significant global mortality and morbidity, with emerging mutant strains continuing to potentially precipitate severe respiratory illness. Two clinical assessment tools, namely, the COVID-19 Risk of Complications Score (CRS), based on 13 comorbidities, and the ALKA (age, lactate dehydrogenase, kidney function, and albumin) score have been developed to predict disease severity among patients who are symptomatic at presentation. This study aimed to compare the performance of these two risk-scoring systems in predicting hospital admission, critical illness, and mortality.

Methods

This retrospective study included 368 patients diagnosed with COVID-19 at SEHA hospitals in Al Ain over a six-month period. The

SUBMITTER: Kurban B 

PROVIDER: S-EPMC12399516 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature